These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7957499)

  • 21. Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population.
    Wang TD; Chen WJ; Chien KL; Seh-Yi Su SS; Hsu HC; Chen MF; Liau CS; Lee YT
    Am J Cardiol; 2001 Oct; 88(7):737-43. PubMed ID: 11589839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LDL-cholesterol and HDL-cholesterol in ischaemic heart disease.
    Atukorala TM; Gunarathna PH; Ekanayake RA; Wijayawardhana UD
    Ceylon Med J; 1986 Mar; 31(1):9-14. PubMed ID: 3802308
    [No Abstract]   [Full Text] [Related]  

  • 23. LDL-cholesterol as a determinant of coronary heart disease.
    Hunninghake D
    Clin Ther; 1990; 12(5):370-5; discussion 369. PubMed ID: 2268861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethnic variation of cord plasma apolipoprotein levels in relation to coronary risk level: a study in three ethnic groups of Singapore.
    Low PS; Saha N; Tay JS; Hong S
    Acta Paediatr; 1996 Dec; 85(12):1476-82. PubMed ID: 9001661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of the patient with a low HDL-cholesterol.
    Leighton RF
    Clin Cardiol; 1990 Aug; 13(8):521-32. PubMed ID: 2204505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary heart disease prevention task force.
    Assmann G; Cullen P; Fruchart C; Lewis B; Mancini M; Carmena R
    Eur Heart J; 1999 Jun; 20(11):841-4. PubMed ID: 10329083
    [No Abstract]   [Full Text] [Related]  

  • 27. Levels of apolipoproteins and cholesterol of low and high density lipoproteins in asymptomatic Chagas disease.
    Cano RC; Rubiolo ER; Santamarina NO
    Medicina (B Aires); 1985; 45(3):269-72. PubMed ID: 3939428
    [No Abstract]   [Full Text] [Related]  

  • 28. Predictive value of lipid profile for salutary coronary angiographic changes in patients on a low-fat diet and physical exercise program.
    Niebauer J; Hambrecht R; Velich T; Marburger C; Hauer K; Kreuzer J; Zimmermann R; von Hodenberg E; Schlierf G; Schuler G; Kübler W
    Am J Cardiol; 1996 Jul; 78(2):163-7. PubMed ID: 8712137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography.
    Whayne TF; Alaupovic P; Curry MD; Lee ET; Anderson PS; Schechter E
    Atherosclerosis; 1981 Jun; 39(3):411-24. PubMed ID: 6942843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation.
    Lehtonen A; Marniemi J; Inberg M; Maatela J; Alanen E; Niittymäki K
    Atherosclerosis; 1986 Feb; 59(2):215-21. PubMed ID: 3083832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study.
    Muntner P; Lee F; Astor BC
    Am J Med Sci; 2011 Mar; 341(3):173-80. PubMed ID: 21042169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low high-density lipoprotein cholesterol and what to do about it.
    Kannel WB
    Am J Cardiol; 1992 Sep; 70(7):810-4. PubMed ID: 1519536
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial.
    Alaupovic P; Fesmire JD; Hunnighake D; Domanski M; Forman S; Knatterud GL; Forrester J; Herd JA; Hoogwerf B; Campeau L; Gobel FL
    Atherosclerosis; 1999 Oct; 146(2):369-79. PubMed ID: 10532693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HDL-cholesterol as a risk factor in coronary heart disease. An update of the Helsinki Heart Study.
    Frick MH; Manninen V; Huttunen JK; Heinonen OP; Tenkanen L; Mänttäri M
    Drugs; 1990; 40 Suppl 1():7-12. PubMed ID: 2289410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ROC curve analysis: an example showing the relationships among serum lipid and apolipoprotein concentrations in identifying patients with coronary artery disease.
    Zweig MH; Broste SK; Reinhart RA
    Clin Chem; 1992 Aug; 38(8 Pt 1):1425-8. PubMed ID: 1643709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy.
    Ballantyne CM; Herd JA; Ferlic LL; Dunn JK; Farmer JA; Jones PH; Schein JR; Gotto AM
    Circulation; 1999 Feb; 99(6):736-43. PubMed ID: 9989957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High density lipoprotein cholesterol low serum level as the only risk factor in male patients with coronary heart disease.
    Alessandri C; Basili S; Peverini F; Barsi R; Paradiso M; Coppotelli L; Violi F; Cordova C
    Clin Ter; 1992 Aug; 141(8):109-14. PubMed ID: 1395453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.
    Rader DJ; Davidson MH; Caplan RJ; Pears JS
    Am J Cardiol; 2003 Mar; 91(5A):20C-23C; discussion 23C-24C. PubMed ID: 12646340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should we measure lipoprotein Lp(a)?
    Wilson PW; Kannel WB
    Arch Intern Med; 1997 Jun; 157(11):1161-2. PubMed ID: 9183225
    [No Abstract]   [Full Text] [Related]  

  • 40. [Apolipoproteins in atherosclerosis].
    Carino C; Rauseo R; Tiboni GM; De Martiis M
    Clin Ter; 1984 Sep; 110(5):477-82. PubMed ID: 6238762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.